# Study of the Orsiro Drug Eluting Stent System

> **NCT01356888** · NA · UNKNOWN · sponsor: **Biotronik AG** · enrollment: 452 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Percutaneous Coronary Intervention (Abbott Laboratories - Xience Prime DES)
- **DEVICE:** Percutaneous Coronary Intervention (Orsiro DES)

## Key facts

- **NCT ID:** NCT01356888
- **Lead sponsor:** Biotronik AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-05
- **Primary completion:** 2013-07
- **Final completion:** 2018-12
- **Target enrollment:** 452 (ACTUAL)
- **Last updated:** 2018-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01356888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01356888, "Study of the Orsiro Drug Eluting Stent System". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01356888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*